# Brainsway Ltd. (BWAY)

- Sector: Healthcare · Industry: Medical Devices
- SEC CIK: 0001505065 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001505065))
- Full page: https://inspectstocks.com/stocks/bway
- Data as of: price 2026-09-28; newest filing used 2026-08-12; latest fiscal period ended 2026-06-30

## Grade

**A** on the balance-sheet rubric used for lenders, 4 of 4 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | $9.4M |  |
| Earnings growing overall | passed | $9.4M | -$13.3M |
| Earnings growing recently | passed | $9.4M | $7.6M |
| Earns well on its assets | passed | 8.3% |  |
| Book value per share growing | not answerable |  | $1.38 |

Business quality (the + / − mark): 3 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 15.6% |  |
| Healthy profit margin | passed | 15.6% |  |
| Strong operating margin | failed | 12.5% |  |
| Good return on equity | failed | 12.9% |  |
| Debt under control | passed | 0.09 |  |
| Turns sales into cash | failed | -2.2% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $60.7M |
| Net income, trailing twelve months | $9.4M |
| Net margin | 15.6% |
| Operating margin | 12.5% |
| Return on equity | 12.9% |
| Debt to equity | 0.09 |
| Diluted EPS, trailing twelve months | $0.24 |
| Share price | $13.23 |
| Market value | $518M |
| Price / earnings | 55.1x |
| Price / sales | 8.5x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/bway)
- [Financial statements](https://inspectstocks.com/stocks/bway/financials)
- [Competitors](https://inspectstocks.com/stocks/bway/peers)
- [Earnings](https://inspectstocks.com/stocks/bway/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.